Professional Bio

Research Bio

Dr. Andolina is interested in improving the outcome for children with cancer through offering enrollment on multi-institutional clinical trials through the Children's Oncology Group (COG) and Pediatric Blood and Marrow Tissue Consortium (PBMTC).

Dr. Andolina has a particular interest in bone marrow transplantation using haploidentical donors. Haploidentical donors are a half match to the patient and include parents, and thus allow nearly all patients in need of a transplant to have an available donor.

Other research interests include evaluating donor anti-HLA antibodies and patient outcome after bone marrow transplant, as well as evaluating reduced-intensity conditioning regimens for children with malignant and non-malignant diseases, especially sickle cell anemia.